We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Genetics of pain perception, COMT and postoperative pain management in children

    Senthilkumar Sadhasivam

    * Author for correspondence

    Clinical Anaesthesia & Paediatrics, Acute & Perioperative Pain Service, Department of Anaesthesia, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, MLC 2001, Cincinnati, OH 45229, USA.

    ,
    Vidya Chidambaran

    Clinical Anaesthesia & Paediatrics, Acute & Perioperative Pain Service, Department of Anaesthesia, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, MLC 2001, Cincinnati, OH 45229, USA

    ,
    Vanessa A Olbrecht

    Clinical Anaesthesia & Paediatrics, Acute & Perioperative Pain Service, Department of Anaesthesia, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, MLC 2001, Cincinnati, OH 45229, USA

    ,
    Hope R Esslinger

    Clinical Anaesthesia & Paediatrics, Acute & Perioperative Pain Service, Department of Anaesthesia, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, MLC 2001, Cincinnati, OH 45229, USA

    ,
    Kejian Zhang

    Division of Human Genetics, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45040, USA

    ,
    Xue Zhang

    Division of Human Genetics, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45040, USA

    &
    Lisa J Martin

    Division of Human Genetics, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45040, USA

    Published Online:https://doi.org/10.2217/pgs.13.248

    Background: Effective perioperative analgesia is lacking for children owing to interindividual variations and underdosing of opioids caused by fear of adverse effects. We investigated the role of COMT SNPs on postoperative pain management in children. Methods: One hundred and forty nine children undergoing adenotonsillectomy were enrolled. The associations of four COMT SNPs (rs6269, rs4633, rs4818 and rs4680) with postoperative pain were analyzed and outcome measures included maximum pain scores, need for postoperative opioid interventions and postoperative morphine requirements. Results: We detected an association of postoperative opioid intervention need with all four COMT SNPs. Minor allele carriers of COMT SNPs were approximately three-times more likely to require analgesic interventions than homozygotes of major alleles (p-value range: 0.0031–0.0127; odds ratio range: 2.6–3.1). In addition, significant association was detected between maximum Face, Leg, Activity, Consolability, Cry (FLACC) pain scores and three COMT SNPs (rs6269, rs4633 and rs4680). Haplotype 1 (ATCA: 51.3%) and Haplotype 2 (GCGG: 36.2%) are more frequent. Haplotype 2 was associated with higher odds of intravenous analgesic intervention need in postanesthesia recovery unit with an odds ratio of 2.6 (95% CI: 1.2–5.4; p-value = 0.022). Conclusion:COMT SNPs may play a significant role in interindividual variation in postoperative pain perception and postoperative morphine requirements in children.

    Original submitted 16 August 2013; Revision submitted 13 December 2013

    References

    • Walco GA, Cassidy RC, Schechter NL. Pain, hurt, and harm. The ethics of pain control in infants and children. N. Engl. J. Med.331(8),541–544 (1994).
    • Berde CB, Sethna NF. Analgesics for the treatment of pain in children. N. Engl. J. Med.347(14),1094–1103 (2002).
    • Beaulieu P, Cyrenne L, Mathews S, Villeneuve E, Vischoff D. Patient-controlled analgesia after spinal fusion for idiopathic scoliosis. Int. Orthop.20(5),295–299 (1996).
    • Duedahl TH, Hansen EH. A qualitative systematic review of morphine treatment in children with postoperative pain. Paediatr. Anaesth.17(8),756–774 (2007).
    • Schechter NL, Blankson V, Pachter LM, Sullivan CM, Costa L. The ouchless place: no pain, children’s gain. Pediatrics99(6),890–894 (1997).
    • Ross JR, Rutter D, Welsh K et al. Clinical response to morphine in cancer patients and genetic variation in candidate genes. Pharmacogenomics J.5(5),324–336 (2005).
    • Wachman EM, Hayes MJ, Brown MS et al. Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome. JAMA309(17),1821–1827 (2013).
    • Nackley AG, Tan KS, Fecho K, Flood P, Diatchenko L, Maixner W. Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both β2- and β3-adrenergic receptors. Pain128(3),199–208 (2007).
    • Diatchenko L, Nackley AG, Slade GD et al. Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain125(3),216–224 (2006).
    • 10  Diatchenko L, Slade GD, Nackley AG et al. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum. Mol. Genet.14(1),135–143 (2005).
    • 11  Reyes -Gibby CC, Shete S, Rakvag T et al. Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene. Pain130(1–2),25–30 (2007).
    • 12  Lotta T, Vidgren J, Tilgmann C et al. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry34(13),4202–4210 (1995).
    • 13  Zubieta JK, Heitzeg MM, Smith YR et al. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science299(5610),1240–1243 (2003).
    • 14  Khasar SG, McCarter G, Levine JD. Epinephrine produces a β-adrenergic receptor-mediated mechanical hyperalgesia and in vitro sensitization of rat nociceptors. J. Neurophysiol.81(3),1104–1112 (1999).
    • 15  Sadhasivam S, Chidambaran V. Pharmacogenomics of opioids and perioperative pain management. Pharmacogenomics13(15),1719–1740 (2012).
    • 16  Berthele A, Platzer S, Jochim B et al. COMT Val108/158Met genotype affects the mu-opioid receptor system in the human brain: evidence from ligand-binding, G-protein activation and preproenkephalin mRNA expression. Neuroimage28(1),185–193 (2005).
    • 17  Jimenez N, Anderson GD, Shen DD et al. Is ethnicity associated with morphine’s side effects in children? Morphine pharmacokinetics, analgesic response, and side effects in children having tonsillectomy. Paediatr. Anaesth.22(7),669–675 (2012).
    • 18  Mamie C, Rebsamen MC, Morris MA, Morabia A. First evidence of a polygenic susceptibility to pain in a pediatric cohort. Anesth. Analg.116(1),170–177 (2013).
    • 19  Oertel BG, Schmidt R, Schneider A, Geisslinger G, Lotsch J. The mu-opioid receptor gene polymorphism 118A>G depletes alfentanil-induced analgesia and protects against respiratory depression in homozygous carriers. Pharmacogenet. Genomics16(9),625–636 (2006).
    • 20  Chou WY, Wang CH, Liu PH, Liu CC, Tseng CC, Jawan B. Human opioid receptor A118G polymorphism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy. Anesthesiology105(2),334–337 (2006).
    • 21  Chou WY, Yang LC, Lu HF et al. Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty. Acta Anaesthesiol. Scand.50(7),787–792 (2006).
    • 22  Klepstad P, Rakvag TT, Kaasa S et al. The 118 A>G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease. Acta Anaesthesiol. Scand.48(10),1232–1239 (2004).
    • 23  Coulbault L, Beaussier M, Verstuyft C et al. Environmental and genetic factors associated with morphine response in the postoperative period. Clin. Pharmacol. Ther.79(4),316–324 (2006).
    • 24  Coller JK, Barratt DT, Dahlen K, Loennechen MH, Somogyi AA. ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals. Clin. Pharmacol. Ther.80(6),682–690 (2006).
    • 25  Stern C. The Hardy–Weinberg law. Science97(2510),137–138 (1943).
    • 26  Dai F, Belfer I, Schwartz CE et al. Association of catechol-O-methyltransferase genetic variants with outcome in patients undergoing surgical treatment for lumbar degenerative disc disease. Spine J.10(11),949–957 (2010).
    • 27  De Gregori M, Garbin G, De Gregori S et al. Genetic variability at COMT but not at OPRM1 and UGT2B7 loci modulates morphine analgesic response in acute postoperative pain. Eur. J. Clin. Pharmacol.69(9),1651–1658 (2013).
    • 28  Ahlers SJ, Elens LL, van Gulik L et al. The Val158Met polymorphism of the COMT gene is associated with increased pain sensitivity in morphine-treated patients undergoing a painful procedure after cardiac surgery. Br. J. Clin. Pharmacol.75(6),1506–1515 (2013).
    • 29  Rakvag TT, Klepstad P, Baar C et al. The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients. Pain116(1–2),73–78 (2005).
    • 30  Sadhasivam S, Krekels EH, Chidambaran V et al. Morphine clearance in children: does race or genetics matter? J. Opioid Manag.8(4),217–226 (2012).
    • 101  SISA. www.quantitativeskills.com/sisa/ (Accessed 10 October 2012)